Model Portfolio ChannelThe BioRevolution: An ETF That Taps Into Nearly EverythingBy Max ChenJune 21, 2021
Multi-Factor ChannelInvesting for Tomorrow, Today: Exploring the Future of Health CareBy Max ChenApril 28, 2021
Equity ETF ChannelPlay the Technology Side of Healthcare with the IHI ETFBy Ben HernandezApril 13, 2021
Leveraged & Inverse ChannelBiden’s Infrastructure Can Put These 2 Leveraged Funds in PlayBy Ben HernandezApril 9, 2021
Innovative ETFs ChannelGreater Regulatory Scrutiny Could Weigh on Biotech ETFsBy Max ChenMarch 24, 2021
Thematic Investing ChannelHealthcare. China. This Global X ETF Combines Two Potent SectorsBy Ben HernandezMarch 3, 2021
Innovative ETFs ChannelIllumina Earnings, Forward Guidance Strengthen Biotech ETFsBy Max ChenFebruary 12, 2021
Innovative ETFs ChannelBiotechnology ETFs Soar on Biogen’s New Alzheimer’s DrugBy Max ChenJanuary 29, 2021
Innovative ETFs ChannelConsider Smaller Biotech ETFs as Big Pharma Goes Shopping in 2021By Max ChenDecember 31, 2020
Disruptive Technology ChannelBad Ideas: The Industries on Innovation’s Chopping BlockBy Max ChenNovember 17, 2020
Innovative ETFs Channel5 Reasons Why Investors Should Consider a Healthcare ETFBy Max ChenNovember 3, 2020
Equity ETF ChannelETF Strategies to Tap into Medical Breakthroughs, Healthcare InnovationsBy Max ChenOctober 30, 2020
